Genmab's total assets for Q3 2025 were kr7.02B, a decrease of -82.86% from the previous quarter. GMAB total liabilities were kr1.27B for the fiscal quarter, a -82.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.